Pfizer fined $106M for 2600% price hike on epilepsy drug

From Published at December 7, 2016 Views 1,563

A British regulator has hit U.S. pharmaceutical giant Pfizer with a record $107 million fine for imposing a 2600% price hike on an anti-epilepsy medication, the latest episode in widening public controversy over prescription drug prices. New York-based Pfizer broke a competition law by "charging excessive and unfair prices" in the United Kingdom for phenytoin sodiumcapsules in Sept.

Read the full article at Bullet-go

  • Report Report as inappropriate
  • Share
    Email Email
    Print Print Twitter Twitter
    Facebook Facebook

Comments (No comments)

Add your comment Reply Down